ARC North Thames PRIMROSE study features in national multimorbidity webinar with Professor Chris Whitty

07 Nov 2021

An NIHR ARC North Thames-supported study, to evaluate interventions to reduce cardiovascular disease risk in people living with severe mental illness, was presented in a national webinar featuring Professor Chris Whitty as the keynote speaker.

The event, led by NIHR ARC East Midlands (ARC EM), shared examples of good practice and research in multiple long term conditions from across a  number of NIHR ARCs and other professionals in this field.

Our Deputy Director Professor David Osborn presented his work on the PRIMROSE-UCLP evaluation, a project jointly led by ARC North Thames and UCLPartners, in collaboration with ARC Yorkshire and Humber (YHARC).

PRIMROSE-A is an intervention to improve the assessment and management of cardiovascular disease (CVD) risk in people with severe mental illnesses such as bipolar disorder, psychosis and schizophrenia. The PRIMROSE-UCLP evaluation project will demonstrate the impact of combining the UCLPartners Proactive Care frameworks with Primrose-A to provide sustainable targeted physical health interventions and economic efficiencies at scale within the existing workforce, amplify health benefits and reduce health inequalities.

More than 220 delegates joined the ‘Managing Multimorbidity: A Virtual Seminar’ on Tuesday 5th October.

The Chief Medical Officer Professor Chris Whitty, who is also the Chief Medical Adviser to the UK government, delivered a keynote presentation on the challenge of multimorbidity and the role of research. The event was chaired by Professor Kamlesh Khunti, Director for NIHR ARC EM and National Lead for The Managing Multimorbidity Theme.

You can watch the full webinar below.


Further links

Glossary 

Related Content